News
Medlab Middle East 2025
Join ViennaLab at Medlab Middle East 2025!
ViennaLab is exhibiting together its long-term partner, HVD Vertriebs, GmbH at booth Z5.C20 and its mother company, BioVendor Group at booth Z5.E29.
When: February 3 - 6, 2025
Where: Dubai World Trade Centre
We are looking forward to meeting you in person!
Extended microbiome assay
Revolutionize your microbiome testing with our comprehensive new Assay
We are thrilled to announce the launch of our latest product, the 16S Microbiome + ITS NGS Assay, which allows for a comprehensive investigation of the human gut microbiome.
This new assay replaces the old version and enables simultaneous detection of both bacterial and fungal species in a single sample without any additional steps. The primers for fungal detection are supplied as an add-on, offering users greater flexibility based on their specific needs.
To learn more about this exciting new product, please check out our brochure and visit the product section of our website.
Holiday Season Greetings 2024
This year is coming to an end and we would like to use this opportunity to thank our business partners, customers, and distribution partners for your trust in us.
We wish you and your loved ones happy holidays and a prosperous New Year 2025!
ViennaLab Team
MEDICA Trade Fair 2024
Join ViennaLab at MEDICA 2024!
From November 11 - 14, 2024, meet us at the Medica Fair 2024 in Düsseldorf.
Together with BioVendor, we’ll be exhibiting exciting innovations in in-vitro diagnostics. Visit us in Hall 3, Booth A92.
Don´t miss the chance to learn more about the latest advances in in-vitro diagnostics!
2024 ESHG Conference in Berlin
ViennaLab is thrilled to announce our participation in the European Human Genetics Conference 2024 in Berlin!
Date: 1 - 4 June 2024
Location: CityCube Berlin, Germany
Stand: #420
Join us as we exhibit alongside our colleagues from BioVendor MDx.
This is a fantastic opportunity to meet the ViennaLab team and explore our cutting-edge diagnostic tools for molecular diagnostics.
NGS Consortium visits ViennaLab
We were honored to host the esteemed monitoring team of the oncNGS consortium (Alleanza Contro il Cancro,Institut Curie,Charité - Universitätsmedizin Berlin, and Institut Jules Bordet) at our facilities in Vienna. The discussions were incredibly productive full of innovative ideas that will shape the future of diagnostics.
It's inspiring to see how this collaboration among European institutions contribute to groundbreaking advancements in diagnostic technologies. Together, we're driving forward the development of cutting-edge innovations that will ultimately improve patient care and outcomes worldwide. For more information follow this link.
Stay tuned for more updates as we continue to push the boundaries of diagnostic excellence!
Medlab Middle East 2024
ViennaLab exhibits at Medlab Middle East 2024!
The event will be held from February 5 - 8, 2024.
ViennaLab is exhibiting together with our long-term partners, HVD VertriebsGmbH at booth Z5.C20 and our mother company, BioVendor Group at booth Z5.E29.
We look forward to meet you in person!
Holiday Season Greetings 2023
Thank you!
This year is coming to an end and we would like to use this opportunity to thank our business partners, customers, and distribution partners for your trust in us.
We wish you and your loved ones happy holidays and a prosperous New Year 2024!
ViennaLab Team
MEDICA Trade Fair 2023
Visit us at MEDICA 2023
The live event will be held from November 13 - 16, 2023 and we will be there.
We are exhibiting together with our mother company, BioVendor, in Hall 3 A92.
We are really looking forward to meet with you again in person!
NGS Contract Award Phase 2
ViennaLab Diagnostics and its partners secured funding for phase 2 of the prestigious oncNGS project.
ViennaLab Diagnostics partnered together with Euformatics and Oncompass Medicine and progressed to the phase 2 to design a state-of-the-art solution which aims to revolutionize the field of liquid biopsy and cancer detection.
Phase 2 will last 12 months, during which, we will apply our expertise to develop a non-invasive Pan-cancer cfDNA test to profile the tumor landscape and predict the best personalized treatment for every patient.
For more information, follow the link to Media Centre announcement. Please click here for the official Press Release.
First IVDR-compliant products!
The EU IVDR 2017/746 directive, commonly referred to as IVDR, provides high levels of patient safety and quality while promoting innovation.
To avoid shortages of in-vitro diagnostic products at service laboratories when the IVDR directive is enforced, ViennaLab has initiated the transition of its products to IVDR by submitting the technical documentation for the first tranche of our RealFast™ Assays and StripAssays® to the Notified Body TÜV Süd and successfully obtaining approval.
This means that we now offer you the following products developed and produced under IVDR:
- alpha-Globin StripAssay [REF 4-160]
- CAH StripAssay [REF 4-380]
- CF StripAssays [REF 4-410, 4-420, 4-430, 4-440]
- FMF StripAssay [4-230]
- FMF-SAA1 StripAssay [REF 4-390]
- HLA-B27 RealFast Assay [REF 7-620/7-623]
By using ViennaLab assays in your diagnostic laboratory, you save valuable time and resources. There is no need to create technical documentation, demonstrate scientific validity, or generate analytical, clinical, and performance data—tasks that are both time-consuming and costly. As an IVD manufacturer, ViennaLab takes care of all these requirements, as confirmed by the certificate issued by the Notified Body TÜV Süd. View this link here.
So, after selecting ViennaLab as your supplier of diagnostic products, you can sit back, relax, and diagnose.
New family member
Think big with a smaller kit configuration
Are you planning a new microbiome project? You do not have many samples to work on at the beginning?
ViennaLab has a perfect solution for you. We now offer a smaller kit configuration – 16 reactions. This attractive set-up is intended to provide an economical solution for new users to familiarize themselves with the assay and for labs with a low sample throughput.
The new configuration is already on stock!
Follow this link to view more details.